These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 91166)

  • 21. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of interleukin 2 (IL-2)-dependent cytotoxic T-cell clones. V. Transfer of resistance to allografts and tumor grafts requires exogenous IL-2.
    Palladino MA; Welte K; Carroll AM; Oettgen HF
    Cell Immunol; 1984 Jul; 86(2):299-307. PubMed ID: 6610478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell surface antigen expression on chemically induced murine leukaemias.
    Birch JM; Moore M; Craig AW
    Br J Cancer; 1975 Jun; 31(6):630-40. PubMed ID: 1174442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on cell surface antigens of mouse leukemic and normal lymphocytes. III. Preparation and characteristics of alloantisera to differentiation antigens of mouse T lymphocytes.
    Kisielow P; Szkudlarek J; Wysocka M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):99-103. PubMed ID: 312094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB
    J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.
    Uenaka A; Ono T; Akisawa T; Wada H; Yasuda T; Nakayama E
    J Exp Med; 1994 Nov; 180(5):1599-607. PubMed ID: 7964448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysis of antigenically unrelated tumor cells mediated by Lyt 2+ splenic T-cells from melphalan-cured MOPC-315 tumor bearers.
    Barker E; Wise JA; Dray S; Mokyr MB
    Cancer Res; 1989 Sep; 49(18):5007-15. PubMed ID: 2788494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of a unique tumor antigen of radiation leukemia virus-induced leukemia B6RV2: its relation to MuLV gp70 of xenotropic class.
    Nakayama E; Uenaka A; DeLeo AB; Stockert E; Obata Y; Ueda R; Inui Y
    J Immunol; 1986 May; 136(9):3502-7. PubMed ID: 3007622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AKR leukemia-specific surface antigens acquired by malignant transformation: their common and individual specificities.
    Okazaki E; Aoki T; De Kozlowski SJ
    Int J Cancer; 1976 May; 17(5):640-6. PubMed ID: 57936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous development of humoral and cellular tumor-specific immunity against L1210 mouse leukemia.
    Kawashima K; Isobe K; Nagase F; Yokochi T; Nagura E; Hasegawa Y; Morishita H; Yamada K; Nakashima I
    Leuk Res; 1985; 9(7):935-9. PubMed ID: 4021540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of a TL(+) murine leukemia cell line that resists the cytotoxic effects of guinea pig complement and specific antiserum.
    Yu A; Liang W; Cohen EP
    J Natl Cancer Inst; 1975 Aug; 55(2):299-308. PubMed ID: 51085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.